Extrapulmonary cytomegalovirus disease in transplant patients.
Petersen
E A
EA
Department of Internal Medicine, University of Arizona, Tucson 85724.
D000998:Antiviral Agents / Q000627:therapeutic use; D016026:Bone Marrow Transplantation; D003586:Cytomegalovirus Infections / Q000175:diagnosis / Q000209:etiology* / Q000628:therapy; D017245:Foscarnet; D015774:Ganciclovir / Q000627:therapeutic use; D016027:Heart Transplantation; D016041:Heart-Lung Transplantation; D006801:Humans; D007167:Immunotherapy; D016030:Kidney Transplantation; D016031:Liver Transplantation; D016377:Organ Transplantation; D010746:Phosphonoacetic Acid / Q000031:analogs & derivatives / Q000627:therapeutic use
D000998:Antiviral Agents; D017245:Foscarnet; D010746:Phosphonoacetic Acid; D015774:Ganciclovir